This may possibly be due to the involvement of compensatory mechanisms as reported
for STAT 3 in response to dasatinib in head and neck cancer and mesothelioma. The objective of this experiment was to analyze the usefulness of mono vs blend remedy on tumor development. None of the therapies brought on any substantial modify in body excess weight indicating no apparent toxicity.
